|
|
Article: Sorin Group Announces Receipt of Offer for the Acquisition of Its Renal Care Business from Investment Consortium Led by Argos Soditic and MPS Venture SGR.
- Article from:
- Business Wire
- Article date:
- October 9, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Prospective Deal confirms strategy to refocus Sorin Group on growth and innovation in its core cardiovascular business portfolio
MILAN, Italy -- Sorin Group (Reuters code: SORN.MI)(MIL:SRN) announced today that it has received an offer for the acquisition of its Renal Care Business and has granted exclusivity to an investment consortium led by Argos Soditic, an independent European private equity firm, and MPS Venture SGR, for the purpose of finalising negotiations. Completion of the transaction is subject to conditions including completion of regulatory procedures for anti-trust and with employee representatives of the Renal Care business in Italy and in France.